Amneal Pharmaceuticals Inc (FRA:2DT)
€ 7.25 -0.05 (-0.68%) Market Cap: 2.31 Bil Enterprise Value: 4.84 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 66/100

Amneal Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2023 / 10:15PM GMT
Release Date Price: €2.02 (-0.98%)
Ekaterina V. Knyazkova
JPMorgan Chase & Co, Research Division - Analyst

Good afternoon, everybody. I'm Ekaterina Knyazkova at JPMorgan, and it is my pleasure to be introducing the Amneal team today. So from the company, we have co-CEO, Chirag Patel, who will be doing a presentation, and then we'll jump into Q&A. So Chirag, Happy New Year. Thank you for joining us and look forward to your remarks.

Chirag K. Patel
Amneal Pharmaceuticals, Inc. - Co-Founder, Co-CEO, President & Director

Thank you, Ekaterina. Very nice to be here. Is this yours? Good afternoon, everybody, and wishing you excellent 2023. We can all use that. And many good years to come by. I know it's a monsoon kind of season outside. I don't know if you saw it around 1:00, it was pouring down. So my name is Chirag Patel. I'm a co-founder and co-CEO of Amneal. It's been a fascinating journey.

It started 20 years ago. So I'm going to walk you through the history a little bit before we jump into where we stand today. It was a very humble beginning. In 2002 in Paterson New Jersey

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot